Pedro Moura‐Alves
- Immunology top 10%
- Immune Response and Inflammation 4
- interferon and immune responses 2
- Immune responses and vaccinations 2
- Inflammation biomarkers and pathways 2
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 3
- Epidemiology top 10%
-
- Inflammasome and immune disorders 3
- Cancer therapeutics and mechanisms 2
-
- Adenosine and Purinergic Signaling 2
- Co-authors
- Stefan H. E. KaufmannElsa AnesNir HacohenGareth GriffithsLuís F. MoitaAvinash SonawaneBibhuti B. MishraAnca Dorhoi
- Journals
- Journal of Clinical Investigation (1 paper)The EMBO Journal (1 paper)Nature reviews. Immunology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Pedro Moura‐Alves
19 papers receiving 973 citations
Peers
Comparison fields: 5 of 100
- Immunology 419
- Infectious Diseases 355
- Cancer Research 140
- Biological Psychiatry 23
- Epidemiology 266
Countries citing papers authored by Pedro Moura‐Alves
This map shows the geographic impact of Pedro Moura‐Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Moura‐Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Moura‐Alves more than expected).
Fields of papers citing papers by Pedro Moura‐Alves
This network shows the impact of papers produced by Pedro Moura‐Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Moura‐Alves. The network helps show where Pedro Moura‐Alves may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pedro Moura‐Alves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 16 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 42 | |
| 6 | 2021 | 43 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 23 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 22 | |
| 12 | 2019 | 33 | |
| 13 | 2018 | 35 | |
| 14 | 2017 | 55 | |
| 15 | 2016 | 30 | |
| 16 | 2016 | 27 | |
| 17 | 2014 | 78 | |
| 18 | 2013 | 237 | |
| 19 | 2011 | 9 | |
| 20 | 2010 | 278 |
About Pedro Moura‐Alves
Pedro Moura‐Alves is a scholar working on Immunology, Physiology and Infectious Diseases, having authored 20 papers that have together received 981 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Tuberculosis Research and Epidemiology (3 papers), Inflammasome and immune disorders (3 papers), interferon and immune responses (2 papers), Immune responses and vaccinations (2 papers), Cancer therapeutics and mechanisms (2 papers), Inflammation biomarkers and pathways (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Immunology (419 citations), Infectious Diseases (355 citations) and Cancer Research (140 citations). Pedro Moura‐Alves has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stefan H. E. Kaufmann, Elsa Anes, Nir Hacohen, Gareth Griffiths, Luís F. Moita, Avinash Sonawane, Bibhuti B. Mishra, Anca Dorhoi, Hans‐Joachim Mollenkopf and Geraldine Nouailles. Their work appears in journals such as Journal of Clinical Investigation, The EMBO Journal and Nature reviews. Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.